{"id":17899,"date":"2021-03-26T08:05:25","date_gmt":"2021-03-26T12:05:25","guid":{"rendered":"https:\/\/medicarereport.org\/?p=17899"},"modified":"2021-03-26T08:05:25","modified_gmt":"2021-03-26T12:05:25","slug":"what-to-make-of-the-astrazeneca-vaccine-data-and-the-surrounding-controversy","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=17899","title":{"rendered":"What to make of the AstraZeneca vaccine data \u2014 and the surrounding controversy"},"content":{"rendered":"<p>(By Adam Feurerstein, Damian Garde, and Meg Tirrell for ST<em>A<\/em>T)<\/p>\n<p>AstraZeneca\u2019s up-and-down quest to develop a vaccine for Covid-19 stands out from what has otherwise been a remarkably straightforward process in the U.S. And the latest twist for AstraZeneca\u2019s vaccine, involving a contentious back-and-forth with federal authorities, only adds confusion to an already muddled process.\u00a0 Continue reading the article <a href=\"https:\/\/www.statnews.com\/2021\/03\/26\/what-to-make-of-the-astrazeneca-vaccine-data-and-the-surrounding-controversy\/\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Adam Feurerstein, Damian Garde, and Meg Tirrell for STAT) AstraZeneca\u2019s up-and-down quest to develop a vaccine for Covid-19 stands<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,14,15],"tags":[],"class_list":["post-17899","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-medical-technology","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17899"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17899\/revisions"}],"predecessor-version":[{"id":17900,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17899\/revisions\/17900"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}